Advertisement

Topics

TriLink BioTechnologies Incorporated Company Profile

03:42 EDT 23rd September 2017 | BioPortfolio

Specialty Oligonucleotides and Nucleoside Triphosphates

TriLink offers cutting edge services to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. TriLink specializes in the modification of oligonucleotides and nucleoside triphosphates. We provide a wide range of services from radioactive labeling to conjugation to custom research.



TriLink manufactures the world’s most extensive line of specialty nucleoside triphosphates. We carry over 120 modified nucleotides. TriLink was founded in 1996 to provide the biopharmaceutical research and industrial communities with high quality products and services that are not readily available elsewhere today.



The three founders of TriLink have over five decades of cumulative experience in the synthesis and labeling of modified oligonucleotides and nucleosides.



We are located approximately 20 minutes north of downtown San Diego, CA in the Sorrento Mesa area.

Location

9955 Mesa Rim Road
San Diego
CA
92121
United States of America

Contact

Phone: (858) 546-0004
Fax: (858) 546-0020


News Articles [117 Associated News Articles listed on BioPortfolio]

TriLink BioTechnologies Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryTriLink BioTechnologies Inc TriLink, a subsidiary of Maravai Life Sciences Inc is a manufacturer of modified nucleic acid products. The company's products include oligonucleotides, nucleotides,...

DGAP-HV: Elanix Biotechnologies AG: -6-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -3-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -4-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -2-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -5-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

Fujifilm Diosynth Biotechnologies opens new UK lab

Fujifilm Diosynth Biotechnologies has opened a $9m process development laboratory in Teeside, UK.

Lion Biotechnologies changes name to Iovance Biotherapeutics

Iovance Biotherapeutics, a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, changed its corporate name from Lion Biotechnologies t...

PubMed Articles [18 Associated PubMed Articles listed on BioPortfolio]

Maintaining US Leadership in Emerging Biotechnologies to Grow the Economy of the Future.

Sourdough-Based Biotechnologies for the Production of Gluten-Free Foods.

Sourdough fermentation, a traditional biotechnology for making leavened baked goods, was almost completely replaced by the use of baker's yeast and chemical leavening agents in the last century. Recen...

Optimization of protocols for Iberian red deer (Cervus elaphus hispanicus) sperm handling before sex sorting by flow cytometry.

Currently, sperm reproductive biotechnologies such as sex sorting and cryopreservation are undoubtedly valuable tools for improving the economic and biological efficiency of red deer production system...

Sharpening the cutting edge: additional considerations for the UK debates on embryonic interventions for mitochondrial diseases.

In October 2015 the UK enacted legislation to permit the clinical use of two cutting edge germline-altering, IVF-based embryonic techniques: pronuclear transfer and maternal spindle transfer (PNT and ...

Is De-extinction Special?

I have been involved with the current interest in de-extinction since early 2012, nearly its beginning. I have given a lot of thought to the potential risks and benefits of de-extinction. But only rec...

Clinical Trials [0 Results]

None

Companies [137 Associated Companies listed on BioPortfolio]

TriLink BioTechnologies

TriLink offers cutting edge services to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. TriLink specializes in the modification of oligonuc...

TriLink BioTechnologies, Inc.

TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp(TM) PCR products for the diagnostic and OEM markets. In addition, custom chemistry, contract research servi...

TriLink BioTechnologies Incorporated

Specialty Oligonucleotides and Nucleoside Triphosphates TriLink offers cutting edge services to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnost...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

More Information about "TriLink BioTechnologies Incorporated" on BioPortfolio

We have published hundreds of TriLink BioTechnologies Incorporated news stories on BioPortfolio along with dozens of TriLink BioTechnologies Incorporated Clinical Trials and PubMed Articles about TriLink BioTechnologies Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TriLink BioTechnologies Incorporated Companies in our database. You can also find out about relevant TriLink BioTechnologies Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...


Corporate Database Quicklinks



Searches Linking to this Company Record